NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

LessIsMore,

Cost averaging and holding during this last year of relative quiet will be seen as a prudent strategy soon enough even if not for everyone which is why consulting an investment advisor is so important in my opinion so I’ll be glad to hear back from you after the MHRA decision news and in the coming years after.
Everyone has different levels of risk tolerance and, as I have said before because of the science and Linda’s tenacity, I believe the only but very real risk with this one has been the time involved for quite some time. But hey, that’s just me and my understanding of the science. Those who wanted a quicker return on equity needed another strategy which is why I haven’t opposed those who trade in and out some without bad mouthing the company. You know this; ). Best wishes.